Sunil Healthcare Reports Negative Performance in Q1 2024 Financial Results
Sunil Healthcare, a microcap pharmaceutical company, reported a negative performance in the quarter ending March 2024, with a score of -6. The company's net sales decreased by 5.4% compared to the previous four quarters, and interest costs have increased by 22.22%. Investors should consider these factors before investing.
Sunil Healthcare, a microcap pharmaceutical company, recently announced its financial results for the quarter ending March 2024. The company's stock has been given a 'Sell' call by MarketsMOJO.
According to the financial report, Sunil Healthcare has seen a negative performance in the quarter, with a score of -6. However, this is an improvement from the previous quarter's score of -19.
One of the main factors contributing to this negative performance is the decline in net sales. The company's net sales for the quarter were Rs 21.31 crore, which is a decrease of 5.4% compared to the average net sales of the previous four quarters, which was Rs 22.54 crore. This indicates a negative trend in the company's sales in the near term.
Another concerning aspect of the financial report is the increase in interest costs. In the last five quarters, Sunil Healthcare's interest costs have been the highest at Rs 1.76 crore, and it has increased by 22.22% compared to the previous quarter. This rise in interest costs suggests that the company has taken on more borrowings.
Overall, the financial results for the quarter ending March 2024 show a decline in sales and an increase in interest costs for Sunil Healthcare. Investors should take note of these factors before making any investment decisions.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
